Crinetics Pharmaceuticals(CRNX) - 2025 Q4 - Earnings Call Transcript

Crinetics Pharmaceuticals (NasdaqGS:CRNX) Q4 2025 Earnings call February 26, 2026 04:30 PM ET Company ParticipantsAlan Krasner - Chief EndocrinologistCatherine Novack - Director of Healthcare Equity ResearchGayathri Diwakar - Head of Investor RelationsIsabel Kalofonos - Chief Commercial OfficerScott Struthers - Founder and CEOToby Schilke - CFOConference Call ParticipantsAlex Thompson - Senior Equity Research AnalystAndy Chen - Director and Senior Equity Research AnalystDennis Ding - VP and Equity Research ...